Axon Enterprise, Inc $AXON Shares Acquired by New York Life Investment Management LLC

New York Life Investment Management LLC increased its position in Axon Enterprise, Inc (NASDAQ:AXON) by 4,560.7% during the third quarter, HoldingsChannel.com reports. The fund owned 633,710 shares of the biotechnology company’s stock after acquiring an additional 620,113 shares during the quarter. Axon Enterprise accounts for approximately 1.8% of New York Life Investment Management LLC’s holdings, making the stock its 9th largest holding. New York Life Investment Management LLC’s holdings in Axon Enterprise were worth $267,755,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other hedge funds have also recently bought and sold shares of AXON. 71 West Capital Partners increased its position in shares of Axon Enterprise by 1,266.0% in the third quarter. 71 West Capital Partners now owns 19,042 shares of the biotechnology company’s stock valued at $8,046,000 after buying an additional 17,648 shares in the last quarter. Pinion Investment Advisors LLC raised its stake in shares of Axon Enterprise by 991.3% during the 3rd quarter. Pinion Investment Advisors LLC now owns 6,548 shares of the biotechnology company’s stock worth $2,767,000 after buying an additional 5,948 shares during the last quarter. Fairscale Capital LLC acquired a new position in shares of Axon Enterprise during the 3rd quarter worth $3,116,000. Retirement Systems of Alabama boosted its position in shares of Axon Enterprise by 12,328.0% in the 3rd quarter. Retirement Systems of Alabama now owns 2,104,560 shares of the biotechnology company’s stock worth $889,219,000 after buying an additional 2,087,626 shares in the last quarter. Finally, Fulcrum Asset Management LLP boosted its position in shares of Axon Enterprise by 94,407.7% in the 3rd quarter. Fulcrum Asset Management LLP now owns 73,716 shares of the biotechnology company’s stock worth $31,146,000 after buying an additional 73,638 shares in the last quarter. 79.08% of the stock is owned by hedge funds and other institutional investors.

Key Axon Enterprise News

Here are the key news stories impacting Axon Enterprise this week:

• Positive Sentiment: Axon is investing $1.2 billion for a 37% stake in drone maker Skydio and will become its U.S. public-safety distributor. The deal could broaden Axon’s public-safety technology offering, though its scale also brings investment and execution risks. Axon invests in Skydio
• Positive Sentiment: West Fargo police plan to replace Flock technology with Axon’s system, including new AI features—an example of continued adoption by public-safety customers. West Fargo police adoption
• Positive Sentiment: Despite lowering its price target, Barclays retained an “overweight” rating at $507; Northland reportedly still sees a $540 target after the stock’s steep fall from its August high. These views suggest some analysts see substantial recovery potential, though targets are not guarantees. Northland target outlook
• Neutral Sentiment: A short-interest report lists 0 shares short, despite describing a large increase. The figure appears inconsistent and does not provide a reliable indication of short-selling pressure.
• Negative Sentiment: Axon’s third-quarter adjusted EPS of $1.72 and revenue of about $909 million fell short of estimates. Cautious guidance and roughly $130 million in federal-contract revenue shifting out of 2026 have weighed on the outlook; shares have fallen sharply since the results, while Motorola rose after its earnings beat. Axon versus Motorola after earnings
• Negative Sentiment: Law firms announced investigations into potential securities-law violations. These are allegations under investigation, not findings of wrongdoing, but may add legal and reputational uncertainty for investors. Axon securities investigation notice

Axon Enterprise Stock Performance

Axon Enterprise stock opened at $302.54 on Wednesday. The company has a debt-to-equity ratio of 0.76, a quick ratio of 2.60 and a current ratio of 3.00. The stock has a fifty day moving average of $430.30 and a two-hundred day moving average of $472.14. The company has a market capitalization of $24.58 billion, a price-to-earnings ratio of 96.97, a PEG ratio of 5.76 and a beta of 1.48. Axon Enterprise, Inc has a fifty-two week low of $291.45 and a fifty-two week high of $665.07.

Axon Enterprise (NASDAQ:AXON) last released its quarterly earnings results on Thursday, November 5th. The biotechnology company reported $1.72 earnings per share for the quarter, missing analysts’ consensus estimates of $1.89 by ($0.17). Axon Enterprise had a return on equity of 3.87% and a net margin of 7.56%. The company had revenue of $908.55 million during the quarter, compared to analyst estimates of $934.33 million. During the same period last year, the firm earned $1.17 earnings per share. The business’s revenue was up 27.8% compared to the same quarter last year. On average, analysts anticipate that Axon Enterprise, Inc will post 2.10 EPS for the current fiscal year.

Analysts Set New Price Targets

A number of brokerages recently commented on AXON. Morgan Stanley increased their price objective on shares of Axon Enterprise from $600.00 to $640.00 and gave the company an “overweight” rating in a research note on Thursday, August 6th. Zacks Research downgraded shares of Axon Enterprise from a “strong-buy” rating to a “hold” rating in a report on Tuesday, November 3rd. UBS Group lifted their target price on shares of Axon Enterprise from $440.00 to $600.00 and gave the stock a “neutral” rating in a research report on Thursday, August 6th. The Goldman Sachs Group reduced their price target on shares of Axon Enterprise from $715.00 to $675.00 and set a “buy” rating on the stock in a report on Monday, September 21st. Finally, Northland Securities set a $540.00 price target on shares of Axon Enterprise in a report on Friday. Thirteen research analysts have rated the stock with a Buy rating and four have issued a Hold rating to the company. Based on data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average target price of $612.18.

Insider Buying and Selling

In related news, CEO Patrick W. Smith sold 10,000 shares of the business’s stock in a transaction dated Tuesday, September 8th. The shares were sold at an average price of $508.99, for a total value of $5,089,900.00. Following the completion of the transaction, the chief executive officer owned 3,118,012 shares of the company’s stock, valued at approximately $1,587,036,927.88. The trade was a 0.32% decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Jeffrey C. Kunins sold 9,605 shares of the company’s stock in a transaction dated Friday, August 21st. The shares were sold at an average price of $626.70, for a total transaction of $6,019,453.50. Following the completion of the transaction, the insider owned 97,761 shares in the company, valued at approximately $61,266,818.70. This trade represents a 8.95% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold 37,397 shares of company stock worth $21,234,034 in the last ninety days. 4.20% of the stock is currently owned by insiders.

Axon Enterprise Company Profile

Axon Enterprise develops technology and services for public safety agencies. Its products include TASER conducted-energy weapons, body-worn and in-car cameras, and related hardware designed to support law enforcement and other safety professionals. The company also provides cloud-based software for managing digital evidence, records and operational workflows. Its Axon Evidence platform helps agencies store, organize and share video and other evidence, while its broader software offerings include tools for dispatch and records management.